Welcome
Support Centre
29 August 2008 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   UKCTG  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
UKCTG
mental health register
archived registers
all registers
tips on searching
 
Registration
submit trials
 
Information
about mRCT
mRCT FAQs
data items
memorandum
contributors

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
A Randomised trial of Adjuvant Chemotherapy (ECF) in Biliary Cancer
Source of recordUK Clinical Trials Gateway
ISRCTNISRCTN18496239
Date ISRCTN assigned19/08/2002
Local reference number(s)RMH E/C 1325
Public titleA Randomised trial of Adjuvant Chemotherapy (ECF) in Biliary Cancer
Scientific title
AcronymN/A
Disease/condition/study domainBiliary tract cancer
Study hypothesisNot provided at time of registration
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteria1. Histological confirmed carcinoma of biliary tract or gall bladder
2. Disease considered to have been completely resected
3. No metastases on staging
Participants - exclusion criteriaNot provided at time of registration
Patient information material
Anticipated start date01/01/2000
Anticipated end date28/02/2002
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsTwo Arms:
1. ECF - 5-Fluorouracil (5FU) 200 mg/m2 continuous infusion daily Epirubicin 50 mg/m2 3 weekly IV bolus Cisplatin 60 mg/m2 3 weekly
2. No treatment
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
Sources of fundingRoyal Marsden Hospital (UK)
Sponsor nameRoyal Marsden Hospital (UK)
Sponsor detailsDowns Road
Sutton
United Kingdom
SM2 5PT
Sponsor telephone+44 (0)20 8661 3156
Sponsor fax+44 (0)20 8643 9414
Sponsor emaildavid.cunningham@rmh.nhs.uk
Contact nameDr - -
Contact detailsUKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
London
United Kingdom
NW1 2DA
Contact telephone+44 (0) 20 7670 4723
Contact fax+44 (0) 20 7670 4818
Contact emailregister@ctu.mrc.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN18496239
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol Top studies in medical research Submit to Trials journal
terms & conditions | privacy statement | © Current Controlled Trials Ltd


BioMed Central